201 related articles for article (PubMed ID: 19090718)
1. A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.
Yoon H; Blaber SI; Debela M; Goettig P; Scarisbrick IA; Blaber M
Biol Chem; 2009 Apr; 390(4):373-7. PubMed ID: 19090718
[TBL] [Abstract][Full Text] [Related]
2. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
[TBL] [Abstract][Full Text] [Related]
3. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression of Kallikreins in Breast Cancer Cell Lines.
Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R
Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response.
Filippou PS; Ren AH; Soosaipillai A; Safar R; Prassas I; Diamandis EP; Conner JR
Clin Biochem; 2020 Mar; 77():41-47. PubMed ID: 31904348
[TBL] [Abstract][Full Text] [Related]
6. A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer.
Lovell S; Zhang L; Kryza T; Neodo A; Bock N; De Vita E; Williams ED; Engelsberger E; Xu C; Bakker AT; Maneiro M; Tanaka RJ; Bevan CL; Clements JA; Tate EW
J Am Chem Soc; 2021 Jun; 143(23):8911-8924. PubMed ID: 34085829
[TBL] [Abstract][Full Text] [Related]
7. Functional roles of human kallikrein-related peptidases.
Sotiropoulou G; Pampalakis G; Diamandis EP
J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
9. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
[TBL] [Abstract][Full Text] [Related]
10. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
11. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Scorilas A; Mavridis K
Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
[TBL] [Abstract][Full Text] [Related]
12. Temporal and tissue-specific expression of kallikrein (Klk) genes and identification of a novel Klk messenger ribonucleic acid transcript during early development in the mouse.
Chan CS; Harvey MB; Clements JA
Biol Reprod; 1999 Sep; 61(3):621-8. PubMed ID: 10456837
[TBL] [Abstract][Full Text] [Related]
13. Interdependence of kallikrein-related peptidases in proteolytic networks.
Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
[TBL] [Abstract][Full Text] [Related]
14. The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2009; 20(11-12):758-67. PubMed ID: 19953256
[TBL] [Abstract][Full Text] [Related]
15. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J; Hooper J; Dong Y; Harvey T
Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.
Radulovic M; Yoon H; Larson N; Wu J; Linbo R; Burda JE; Diamandis EP; Blaber SI; Blaber M; Fehlings MG; Scarisbrick IA
J Neuropathol Exp Neurol; 2013 Nov; 72(11):1072-89. PubMed ID: 24128681
[TBL] [Abstract][Full Text] [Related]
17. Activation and activity of glycosylated KLKs 3, 4 and 11.
Guo S; Briza P; Magdolen V; Brandstetter H; Goettig P
Biol Chem; 2018 Sep; 399(9):1009-1022. PubMed ID: 29975661
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and expression of five novel canine kallikrein-related peptidases in mammary cancer.
Angelopoulou K; Karagiannis GS
Mamm Genome; 2010 Oct; 21(9-10):516-24. PubMed ID: 20853168
[TBL] [Abstract][Full Text] [Related]
19. Copy number variants in the kallikrein gene cluster.
Lindahl P; Säll T; Bjartell A; Johansson AM; Lilja H; Halldén C
PLoS One; 2013; 8(7):e69097. PubMed ID: 23894413
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.
Geng X; Liu Y; Diersch S; Kotzsch M; Grill S; Weichert W; Kiechle M; Magdolen V; Dorn J
PLoS One; 2017; 12(11):e0186847. PubMed ID: 29095848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
